Serum angiopoietin-2 levels predict regression of Mac-2 binding protein glycosylation isomer-based liver fibrosis after hepatitis C virus eradication by direct-acting antiviral agents.
Takanori SuzukiKentaro MatsuuraYoshihito NaguraShintaro OgawaKei FujiwaraShunsuke NojiriTakehisa WatanabeHiromi KataokaYasuhito TanakaPublished in: Hepatology research : the official journal of the Japan Society of Hepatology (2022)
The serum Ang-2 level at 24 weeks after the EOT is a feasible predictor of regression of M2BPGi-based liver fibrosis after achieving SVR by DAA therapy.